Home  >  News
Marketing
+ Font Resize -

Dr Reddy's Labs to market PanTheryx's infectious diarrhoea product, DiaResQ in India & Nepal

Our Bureau, Mumbai
Thursday, September 10, 2015, 13:15 Hrs  [IST]

Dr Reddy's Laboratories (DRL) and PanTheryx, Inc., a global medical nutrition company based in Boulder, Colorado have entered a multi-country supply and licensing agreement. DRL will get the exclusive right to market and distribute PanTheryx’s breakthrough nutritional intervention, DiaResQ, for infectious diarrhoea in India and Nepal and in process for Russia, Myanmar, Vietnam, Ukraine, Sri Lanka, Kazakhstan, Belarus,  Jamaica, and select LATAM markets. Dr Reddy’s will market the product in India and Nepal under the “Reliqua” brand.  

DiaResQ helps promote intestinal repair and boost natural immune defenses, resulting in the restoration of normal digestive function. The product was recently recognized in Reimagining Global Health as one of the 30 leading healthcare innovations with great promise to transform global health by 2030.

“The opportunity to work with Dr Reddy’s to broadly introduce DiaResQ represents a significant milestone for our company,” said Mark A Braman, president and CEO of PanTheryx. “Dr Reddy’s is the recognized leader in the gastrointestinal market, and this agreement covers some of the largest and most promising markets throughout the world for PanTheryx and its products. This partnership further validates DiaResQ’s potential to improve the well-being and quality of life of millions of children and their families globally.”

Dr. Reddy’s co-chairman and CEO, GV Prasad stated “This innovative product will address a significant unmet need in the area of diarrhoea. By adding Reliqua to our existing portfolio of gastrointestinal brands, Dr Reddy’s can provide an important new tool for healthcare practitioners across the many markets we serve. Our agreement with PanTheryx is another step towards ensuring good health can be delivered to those who need it.”

Infectious diarrhoea is a major world health challenge. Globally, approximately 1.7 billion cases occur annually in children under five. Almost 760,000 of these children under five die every year as a result of this condition. Paediatric infectious diarrhoea kills nearly as many children as HIV/AIDS, malaria and measles combined.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
IPJPI_150x60en_2017
CPhI-WWW-150x60-stat-v1
IPJPI_150x60en_2017
IPJPI_150x60en_2017
chemspec2017
chemspec2017
chemspec2017
cphikorea_150x60_k
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |